01.10.2010 | Original report
Very low rates of neutropenic complications and chemotherapy dose modifications in early breast cancer patients receiving adjuvant FEC-100 or TAC and an individualised G-CSF and anti-infective support: results of a retrospective chart review
Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2010
Einloggen, um Zugang zu erhaltenAnzeige